Search Results for citation:"89 FR 101048"

Found 2 results
Skip to main content

Search Results: citation:"89 FR 101048"

  • Type:Notice
    Citation:89 FR 101048
    Reading Time:about 3 minutes

    The United States International Trade Commission (USITC) determined that domestic industries in the U.S. are likely being harmed by imports of hard empty capsules from China, India, and Vietnam, which are being sold at unfairly low prices. Additionally, imports from Brazil pose a threat of material injury due to government subsidies. This triggered the start of final phase investigations, with the USITC collecting more information and preparing for further actions. The investigations were initiated following a petition by Lonza Greenwood LLC, leading to hearings and conferences in November 2024, with determinations filed by December 9, 2024.

    Simple Explanation

    The US said that some countries like China, India, Vietnam, and Brazil were sending special capsules to the US for too little money, which was hurting the people who make them in America. Now, the US wants to look into this more to figure out what’s really going on and decide what to do next.

  • Type:Notice
    Citation:89 FR 101048
    Reading Time:about 5 minutes

    The U.S. International Trade Commission is investigating potential violations related to products containing tirzepatide. On December 6, 2024, an administrative law judge issued an initial determination that partially found a violation of Section 337. The Commission is seeking public comments on the potential impact of excluding these products from the U.S. market or issuing cease and desist orders. Comments should address how these actions might affect public health, the economy, and consumer interests in the United States. Written submissions are due by January 8, 2025.

    Simple Explanation

    The government is checking if some products with a special ingredient called tirzepatide are breaking trade rules and wants to hear what people think about stopping these products from being sold in the U.S. because it might affect things like people's health and shopping choices.